Obesity currently affects more than 2 in 5 adults in the United States and demonstrates significant associations with cardiovascular disease, type 2 diabetes (T2D), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH), osteoarthritis, sleep disorders, and reproductive health complications. Obesity care continues to evolve with advancing treatment options, emerging best practices in comorbidity management, and evidence-based guidance on patient-centered approaches, creating new opportunities to improve outcomes for patients living with obesity.
To support clinicians in comprehensive obesity management, this educational initiative will facilitate peer-to-peer learning, case-based discussions, and practical guidance through simulation-based scenarios. Participants will gain enhanced competence in recognizing and managing the relationships between obesity and a range of comorbidities, develop skills in creating individualized treatment plans that integrate evidence-based pharmacological and lifestyle interventions, and strengthen patient-centered communication strategies that support treatment adherence and improved patient outcomes.
CME/CE Accreditation Information
In the United States, obesity and overweight are an epidemic and a major health concern worldwide. Excess adipose tissue can lead to diabetes, hypertension, cardiovascular disease, certain cancers, poor mental health, and musculoskeletal disorders, resulting in decreased quality of life and increased mortality. While lifestyle modifications are a cornerstone of obesity and overweight management, most patients do not achieve durable results, highlighting a need for pharmacological interventions. This educational curriculum will help primary care clinicians identify patients with obesity who could benefit from weight-loss medicines and integrate evidence-based strategies for motivational interviewing and shared decision-making to improve outcomes for patients with obesity.
CME/CE Accreditation Information
In the United States, obesity and overweight are an epidemic and a major health concern worldwide. Excess adipose tissue can lead to diabetes, hypertension, cardiovascular disease, certain cancers, poor mental health, and musculoskeletal disorders, resulting in decreased quality of life and increased mortality. While lifestyle modifications are a cornerstone of obesity and overweight management, most patients do not achieve durable results, highlighting a need for pharmacological interventions. This educational curriculum will help primary care clinicians identify patients with obesity who could benefit from weight-loss medicines and integrate evidence-based strategies for motivational interviewing and shared decision-making to improve outcomes for patients with obesity.
CME/CE Accreditation Information
